Skip to main content
Download PDF
- Main
Embryonic Stem Cell–Derived Cardiac Myocytes Are Not Ready for Human Trials
Published Web Location
https://doi.org/10.1161/circresaha.114.304616Abstract
Recently a preclinical report assessed the efficacy, safety, and feasibility of using human embryonic stem cells to regenerate infarcted myocardium in a non-human primate model. This commentary evaluates that study by pointing out key weaknesses, offering an alternative perspective, and summarizing major unresolved issues. Our conclusion is that significant challenges remain before human embryonic stem cells are ready for use in clinical trials.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.